Antimicrobial skin peptides in premature infants: Comparison with term infants and impact of perinatal factors

Introduction Preterm infants have an immature epidermis barrier function that may lead to an increased permeability to pathogens. On the surface of the human skin, antimicrobial peptides (AMPs) are important molecules of the innate immune system, have broad antimicrobial properties, and provide an essential role in integrity of the microbiome. Given the marked susceptibility of preterm infants to infection, we hypothesize a decreased expression of AMPs on the skin of preterm infants. Materials and methods In a prospective single-center study with 35 preterm and 20 term infants, we analyzed skin rinsing probes for the presence of the AMPs psoriasin (S100A7) and ribonuclease 7 (RNase 7) via enzyme-linked immunosorbent assay. Samples were taken from preterm infants < 34 0/7 weeks gestational age (mean ± SD gestational age, 28.8 ± 2.4 weeks) on days 0, 7, 14, and 28 after birth. Term infants (> 36 6/7 weeks) (controls) were washed on days 0 and 28. Results Psoriasin and RNase 7 were both expressed on skin of preterm and term infants and increased in concentration significantly over time. RNase 7 was more expressed in term infants on day 0 [preterm = 1.1 (0.7–2.9) vs. term = 2.0 (1.1–3.4) ng/ml, p = 0.017]. On day 28, premature infants showed higher values of psoriasin [preterm = 10.9 (5.6–14.2) vs. term = 6.3 (3.4–9.0) ng/ml, p < 0.001]. Notably, preterm infants with infectious or inflammatory context driven by histological proof of chorioamnionitis and early-onset or late-onset sepsis had higher concentrations of psoriasin as compared with non-affected preterm infants. After exclusion of infants with inflammatory hit, median concentrations of RNase 7 and psoriasin did not differ between preterm and full-term infants on days 0 and 28. Discussion Psoriasin and RNase 7 concentrations increase over time on the skin of newborn infants and seem to play a role in the first defense against infection. This is of particularly interest as the role of AMPs on a maturing skin microbiome and its possible new prevention strategies is unclear and needs to be determined.

[1]  M. de Zwaan,et al.  Skin microbiota analysis in patients with anorexia nervosa and healthy-weight controls reveals microbial indicators of healthy weight and associations with the antimicrobial peptide psoriasin , 2022, Scientific Reports.

[2]  J. Harder,et al.  Antimicrobial peptides and proteins: Interaction with the skin microbiota , 2021, Experimental dermatology.

[3]  E. Middelkoop,et al.  Review: Lessons Learned From Clinical Trials Using Antimicrobial Peptides (AMPs) , 2021, Frontiers in Microbiology.

[4]  N. Nakamura,et al.  Tape stripping method is useful for the quantification of antimicrobial peptides on the human skin surface including the stratum corneum , 2020, Scientific Reports.

[5]  W. Göpel,et al.  Preterm birth and sustained inflammation: consequences for the neonate , 2020, Seminars in Immunopathology.

[6]  N. Lévêque,et al.  Antiviral and Immunomodulatory Properties of Antimicrobial Peptides Produced by Human Keratinocytes , 2020, Frontiers in Microbiology.

[7]  T. Werfel,et al.  The Antimicrobial and Immunomodulatory Function of RNase 7 in Skin , 2019, Front. Immunol..

[8]  Ying Dong,et al.  Beyond sepsis: Staphylococcus epidermidis is an underestimated but significant contributor to neonatal morbidity , 2018, Virulence.

[9]  Amélie Collins,et al.  Why are preterm newborns at increased risk of infection? , 2018, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[10]  B. Stoll,et al.  Neonatal sepsis , 2017, The Lancet.

[11]  F. Niyonsaba,et al.  Friends or Foes? Host defense (antimicrobial) peptides and proteins in human skin diseases , 2017, Experimental dermatology.

[12]  O. Levy,et al.  Antimicrobial Proteins and Peptides in Early Life: Ontogeny and Translational Opportunities , 2016, Front. Immunol..

[13]  B. Becknell,et al.  A Review of Ribonuclease 7’s Structure, Regulation, and Contributions to Host Defense , 2016, International journal of molecular sciences.

[14]  T. Agner,et al.  In vivo expression of antimicrobial peptides in atopic dermatitis , 2016, Experimental dermatology.

[15]  Mauricio Odio,et al.  Newborn infant skin: physiology, development, and care. , 2015, Clinics in dermatology.

[16]  S. Straube,et al.  [New percentile values for the anthropometric dimensions of singleton neonates: analysis of perinatal survey data of 2007-2011 from all 16 states of Germany]. , 2014, Zeitschrift fur Geburtshilfe und Neonatologie.

[17]  K. McHugh,et al.  Ribonucleases 6 and 7 have antimicrobial function in the human and murine urinary tract , 2014, Kidney international.

[18]  W. Göpel,et al.  Differential expression of antimicrobial polypeptides in cord blood samples of preterm and term infants , 2014, Acta paediatrica.

[19]  P. Gastmeier,et al.  P241: Nosocomial infections in very low birthweight infants in germany: current data from the national surveillance system neo-kiss , 2013, Antimicrobial Resistance and Infection Control.

[20]  J. Hedderich,et al.  Differential expression and in vivo secretion of the antimicrobial peptides psoriasin (S100A7), RNase 7, human beta‐defensin‐2 and ‐3 in healthy human skin , 2013, Experimental dermatology.

[21]  Hideoki Ogawa,et al.  Human antimicrobial peptide LL-37 modulates proinflammatory responses induced by cytokine milieus and double-stranded RNA in human keratinocytes. , 2013, Biochemical and biophysical research communications.

[22]  C. Fiala,et al.  Prenatal human skin expresses the antimicrobial peptide RNase 7 , 2013, Archives of Dermatological Research.

[23]  P. Gastmeier,et al.  P241: Nosocomial infections in very low birthweight infants in germany: current data from the national surveillance system neo-kiss , 2013, Antimicrobial Resistance and Infection Control.

[24]  J. Postberg,et al.  Human β-defensin 2 expression in ELBW infants with severe necrotizing enterocolitis , 2012, Pediatric Research.

[25]  J. Schröder,et al.  Antimicrobial RNases in Cutaneous Defense , 2012, Journal of Innate Immunity.

[26]  S. Ygberg,et al.  The developing immune system – from foetus to toddler , 2012, Acta paediatrica.

[27]  J. Harder,et al.  Psoriasin: key molecule of the cutaneous barrier? , 2011, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[28]  S. Dowd,et al.  Diversity of the Human Skin Microbiome Early in Life , 2011, The Journal of investigative dermatology.

[29]  U. Mrowietz,et al.  Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury. , 2010, The Journal of investigative dermatology.

[30]  Winfried Schuller,et al.  UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo. , 2009, The Journal of allergy and clinical immunology.

[31]  A. Di Nardo,et al.  Cathelicidin Antimicrobial Peptides Block Dendritic Cell TLR4 Activation and Allergic Contact Sensitization1 , 2007, The Journal of Immunology.

[32]  V. Nizet,et al.  Keratinocyte Production of Cathelicidin Provides Direct Activity against Bacterial Skin Pathogens , 2005, Infection and Immunity.

[33]  I. Nagaoka,et al.  The Human β-Defensins (-1, -2, -3, -4) and Cathelicidin LL-37 Induce IL-18 Secretion through p38 and ERK MAPK Activation in Primary Human Keratinocytes1 , 2005, The Journal of Immunology.

[34]  V. Nizet,et al.  Cutaneous defense mechanisms by antimicrobial peptides. , 2005, The Journal of investigative dermatology.

[35]  J. Schröder,et al.  Antimicrobial peptides in human skin. , 2005, Chemical immunology and allergy.

[36]  P. McCray,et al.  Expression and Activity of β-Defensins and LL-37 in the Developing Human Lung1 , 2005, The Journal of Immunology.

[37]  H. Lagercrantz,et al.  Antimicrobial Polypeptides of Human Vernix Caseosa and Amniotic Fluid: Implications for Newborn Innate Defense , 2003, Pediatric Research.

[38]  H. Brismar,et al.  The newborn infant is protected by an innate antimicrobial barrier: peptide antibiotics are present in the skin and vernix caseosa , 2002, The British journal of dermatology.

[39]  J. Schröder,et al.  RNase 7, a Novel Innate Immune Defense Antimicrobial Protein of Healthy Human Skin* , 2002, The Journal of Biological Chemistry.

[40]  K. Iwabuchi,et al.  Epithelial cell-derived human beta-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway. , 2002, International immunology.

[41]  R. Bals,et al.  Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection. , 2002, American journal of respiratory and critical care medicine.

[42]  Nikolaus Blin,et al.  Dermcidin: a novel human antibiotic peptide secreted by sweat glands , 2001, Nature Immunology.

[43]  Ji Ming Wang,et al.  Ll-37, the Neutrophil Granule–And Epithelial Cell–Derived Cathelicidin, Utilizes Formyl Peptide Receptor–Like 1 (Fprl1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T Cells , 2000, The Journal of experimental medicine.

[44]  C. Bevins,et al.  Antimicrobial Peptides as Mediators of Epithelial Host Defense , 1999, Pediatric Research.

[45]  R. Allaker,et al.  An investigation into the antimicrobial effects of adrenomedullin on members of the skin, oral, respiratory tract and gut microflora. , 1999, FEMS immunology and medical microbiology.

[46]  H. Leffers,et al.  Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. , 1991, The Journal of investigative dermatology.

[47]  T. Agner,et al.  Antimicrobial Peptides, Infections and the Skin Barrier. , 2016, Current problems in dermatology.

[48]  R. Hentschel,et al.  [New percentile values for the anthropometric dimensions of twin neonates: analysis of perinatal survey data of 2007-2011 from all 16 states of Germany]. , 2014, Zeitschrift fur Geburtshilfe und Neonatologie.